Novel subunit vaccine against chlamydial infection

抗衣原体感染的新型亚单位疫苗

• 批准号: 331314
• 负责人: Liang Steven
• 金额: $ 1.27万
• 依托单位: McMaster University
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2014
• 资助国家: 加拿大
• 起止时间: 2014-12-01 至 2015-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=331314&lang=en
• 关键词: Chlamydia Trachomatis; Copb; Copd; Ct584; Immune Response; Vaccine

Chlamydia trachomatis is a significant pathogen in humans and a major cause of disease burden worldwide. It is responsible for over 6 million cases of blindness in developing countries annually, and is the most common sexually transmitted bacterial infect

沙眼衣原体是人类的重要病原体，也是全世界疾病负担的主要原因。它每年导致发展中国家超过 600 万例失明，是最常见的性传播细菌感染